⨯

  • 12 Apr 19

Executive interview - Selvita

Executive interview - Selvita

Ryvu Therapeutics SA | SLVPLN | 0 90.0 0.9%
Follow Company Follow Company

    • 113 views

 

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via the share buttons below. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Cantargia - executive interview

Companies: Cantargia AB

Poolbeg Pharma's Jeremy Skillington says progress with POLB 001 is adding value

Companies: Poolbeg Pharma Ltd.

IRLAB Therapeutics - executive interview

Companies: IRLAB Therapeutics AB Class A

Destiny Pharma PLC on its two lead infection prevention assets

Companies: Destiny Pharma Plc

Synairgen PLC on presenting at the ATS conference in San Francisco

Companies: Synairgen plc

Basilea Pharmaceutica - executive interview

Companies: Basilea Pharmaceutica AG

Copyright © 2022 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top